About Coloplast A/S
Coloplast A/S engages in the development, manufacture, and marketing of medical devices and services. The company principally operates in five product areas, including ostomy products for people whose intestinal outlet has been surgically rerouted through the abdominal wall; continence care products for people with problems controlling their bladder or bowel movements; dressings for treatment of chronic wounds; skin care products for prevention and treatment; and breast forms and special textiles for women after breast surgery. Ostomy Coloplast’s ostomy business comprises products and services for people with a surgically created opening in the abdominal wall for the ureter or bowel. People diagnosed with chronic intestinal diseases or cancer may need ostomy surgery. Ostomy bags are for one-time use or drainable, and they consist either of a skin adhesive with integrated bag or of two separate parts for coupling. The company markets its products in Germany, Great Britain and France. Competitors The company’s major competitors are ConvaTec and Hollister, Inc. Continence Care Coloplast engages in the manufacture and sale of appliances to people with problems controlling their bladder or bowel movements. Its key customer group is people with spinal-cord injuries. Its main product groups are catheters for emptying the bladder, urine bags, urisheaths and products to help overcome loss of bowel control. The company markets its products in Great Britain and France. Coloplast initiated a partnership with British Ranier Technology Ltd. to engage in the development and marketing of a new permanent catheter concept. Competition The company’s main competitors in the global marketplace are Astra Tech AB; Mentor Corporation; and Hollister, Inc. Wound Care Coloplast’s wound care business engages in the development, manufacture, marketing, and sale of wound care products supporting the healing of diagnosis-related chronic wounds. Coloplast gives advice to nurses on which indications and wound stages to apply the individual products for. Coloplast is addressing the market defined as the moist wound-healing market, including improved and active products for the healing of chronic wounds. Its product range comprises dressings based on hydrocolloids, hydrogel, foam, alginate and active substances, the main agent being silver. Competition The company’s major competitors include ConvaTec; Smith & Nephew; Molnlycke; and Johnson & Johnson. Skin Health Coloplast’s skin health business engages in the development, manufacturing, global marketing, and sales in USA. Its primary target groups are health professionals and elderly people with skin health problems. Its main products protect skin exposed to body liquids, retain moisture, bathe and cleanse skin, and treat wounds. Its products are sold as accessories for appliances from other Coloplast product areas. The skin health business unit is responsible for sales of Coloplast’s wound care products in the USA as, in this market, these two areas of care are often handled by the same nurses. Competitors The company’s major competitors include ConvaTec; Smith & Nephew; and 3M. Breast Care Coloplast’s breast care business engages in the development, manufacture, and distribution of external breast forms for women who have had a breast surgically removed. The company’s business area also includes underwear, swimsuits, and skin care products especially designed for this target group. Its products are sold under the Amoena brand, through bandagists and specialist shops. Its main markets are the USA, Germany, France, and Great Britain. Competition The company’s major competitors are Anita Dr. Helbig GmbH and TruLife. Markets The company principally markets its products in three regions: Europe, North and South America, Asia-Pacific region. History Coloplast A/S was founded in 1957.
